Key | % Net Assets |
---|---|
Royal Dutch Shell | 9.9% |
BP | 9.5% |
GlaxoSmithKline | 6.0% |
AstraZeneca | 5.9% |
Other | 68.7% |
Name | % Net Assets |
---|---|
Royal Dutch Shell | 9.9% |
BP | 9.5% |
GlaxoSmithKline | 6.0% |
AstraZeneca | 5.9% |
Vodafone | 5.2% |
HSBC | 4.8% |
BAE Systems | 3.5% |
Barclays | 3.5% |
Compass | 3.3% |
BHP Billiton | 3.2% |
No asset data available.
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 14/03/1988 |
---|---|
Fund Manager | Jeff Saunders / John Monnelly |
TER | - |
Minimum Investment | |
---|---|
Initial | 1000000 |
Additional | n/a |
Savings | 100 |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 0.75% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.02 |
You are here: research